question: The U.S. Food and Drug Administration (FDA) guidance and Centers for Disease Control interim guidelines for SARS-CoV-2 testing lists patient self-collected anterior nares swab (ANS) as an acceptable alternative to the standard healthcare provider (HCP)-collected nasopharyngeal swab (NPS) (1, 2).….